Sicart Associates’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.07M | Hold |
80,667
| – | – | 1.56% | 25 |
|
|
2025
Q4 | $4.99M | Sell |
80,667
-254
| -0.3% | -$14.9K | 1.32% | 28 |
|
|
2025
Q3 | $4.75M | Buy |
80,921
+80
| +0.1% | +$4.66K | 1.29% | 26 |
|
|
2025
Q2 | $4.7M | Sell |
80,841
-3,293
| -4% | -$186K | 1.65% | 23 |
|
|
2025
Q1 | $4.22M | Sell |
84,134
-148
| -0.2% | -$7.57K | 1.46% | 29 |
|
|
2024
Q4 | $3.77M | Sell |
84,282
-5,692
| -6% | -$270K | 1.35% | 31 |
|
|
2024
Q3 | $4.38M | Buy |
89,974
+200
| +0.2% | +$9.64K | 1.54% | 27 |
|
|
2024
Q2 | $4.62M | Sell |
89,774
-794
| -0.9% | -$43.5K | 1.77% | 26 |
|
|
2024
Q1 | $4.98M | Sell |
90,568
-358
| -0.4% | -$18.7K | 1.82% | 21 |
|
|
2023
Q4 | $5.2M | Sell |
90,926
-4,814
| -5% | -$272K | 1.99% | 19 |
|
|
2023
Q3 | $5.99M | Buy |
95,740
+1,942
| +2% | +$123K | 2.35% | 16 |
|
|
2023
Q2 | $5.59M | Sell |
93,798
-2,646
| -3% | -$168K | 2.17% | 16 |
|
|
2023
Q1 | $7.16M | Sell |
96,444
-23,944
| -20% | -$1.85M | 2.79% | 13 |
|
|
2022
Q4 | $8.84M | Sell |
120,388
-4,400
| -4% | -$348K | 3.12% | 10 |
|
|
2022
Q3 | $10.5M | Sell |
124,788
-22,658
| -15% | -$1.95M | 3.73% | 6 |
|
|
2022
Q2 | $11.8M | Sell |
147,446
-38,104
| -21% | -$3.7M | 3.67% | 6 |
|
|
2022
Q1 | $19.3M | Sell |
185,550
-42,785
| -19% | -$3.55M | 4.99% | 2 |
|
|
2021
Q4 | $17.1M | Sell |
228,335
-510
| -0.2% | -$35.7K | 4.46% | 5 |
|
|
2021
Q3 | $15M | Sell |
228,845
-21,540
| -9% | -$1.32M | 4.08% | 4 |
|
|
2021
Q2 | $15.3M | Sell |
250,385
-3,540
| -1% | -$209K | 3.64% | 6 |
|
|
2021
Q1 | $13.8M | Sell |
253,925
-78,595
| -24% | -$4.27M | 3.65% | 8 |
|
|
2020
Q4 | $16.1M | Buy |
332,520
+5,069
| +2% | +$224K | 3.98% | 5 |
|
|
2020
Q3 | $12.9M | Sell |
327,451
-270
| -0.1% | -$9.83K | 3.86% | 7 |
|
|
2020
Q2 | $10.6M | Buy |
327,721
+132,340
| +68% | +$4.61M | 3.4% | 8 |
|
|
2020
Q1 | $6.69M | Buy |
195,381
+84,875
| +77% | +$3.4M | 2.55% | 9 |
|
|
2019
Q4 | $5.35M | Sell |
110,506
-4,922
| -4% | -$238K | 1.78% | 17 |
|
|
2019
Q3 | $5.81M | Buy |
115,428
+190
| +0.2% | +$9.7K | 1.91% | 17 |
|
|
2019
Q2 | $6.23M | Sell |
115,238
-11,600
| -9% | -$606K | 2.53% | 13 |
|
|
2019
Q1 | $6.75M | Hold |
126,838
| – | – | 2.85% | 11 |
|
|
2018
Q4 | $6.01M | Buy |
126,838
+4,690
| +4% | +$245K | 2.91% | 10 |
|
|
2018
Q3 | $7.1M | Hold |
122,148
| – | – | 3.4% | 6 |
|
|
2018
Q2 | $6.68M | Sell |
122,148
-1,810
| -1% | -$89.8K | 3.5% | 7 |
|
|
2018
Q1 | $5.86M | Buy |
+123,958
| New | +$6.21M | 3.5% | 7 |
|
Other funds holding NTR
VCM
Sicart Associates's NTR Position: Q1 2026 in Review
Sicart Associates held its Nutrien (NTR) position steady in Q1 2026 at 80,667 shares worth $6.07M. The position accounts for 1.56% of the portfolio, ranked #25.
Sicart Associates first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $19.3M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Sicart Associates held 80,667 shares of Nutrien worth $6.07M as of Q1 2026.
- Sicart Associates left its Nutrien share count unchanged in Q1 2026.
- Nutrien made up 1.56% of Sicart Associates's portfolio in Q1 2026, its #25 holding.
- Sicart Associates first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Sicart Associates's Nutrien position peaked at $19.3M in Q1 2022.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Sicart Associates's 13F filing for Q1 2026, filed 21 Apr 2026.